Doug Schenkel
Stock Analyst at Wolfe Research
(3.62)
# 792
Out of 4,876 analysts
66
Total ratings
54.17%
Success rate
35.19%
Average return
Main Sectors:
Stocks Rated by Doug Schenkel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TEM Tempus AI | Initiates: Outperform | $60 | $66.52 | -9.80% | 1 | Dec 13, 2024 | |
| HOLX Hologic | Initiates: Peer Perform | n/a | $65.01 | - | 5 | Dec 13, 2024 | |
| TWST Twist Bioscience | Initiates: Outperform | $60 | $35.93 | +66.99% | 2 | Dec 13, 2024 | |
| STVN Stevanato Group | Initiates: Outperform | $28 | $24.64 | +13.64% | 1 | Dec 13, 2024 | |
| WST West Pharmaceutical Services | Initiates: Peer Perform | n/a | $218.87 | - | 1 | Dec 13, 2024 | |
| RGEN Repligen | Initiates: Peer Perform | n/a | $123.56 | - | 1 | Nov 14, 2024 | |
| MRVI Maravai LifeSciences Holdings | Initiates: Peer Perform | n/a | $2.47 | - | 1 | Nov 14, 2024 | |
| DHR Danaher | Upgrades: Outperform | $285 | $198.80 | +43.36% | 2 | Oct 31, 2024 | |
| BRKR Bruker | Downgrades: Peer Perform | n/a | $41.80 | - | 2 | Sep 30, 2024 | |
| A Agilent Technologies | Downgrades: Peer Perform | n/a | $119.17 | - | 8 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $52 | $47.77 | +7.81% | 2 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $11.73 | - | 3 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $94.79 | - | 5 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $53.65 | - | 4 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $408.28 | - | 3 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $5.27 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $97.82 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $1.29 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $13.53 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $50.86 | - | 2 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $167.96 | - | 3 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $352.41 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $3.10 | - | 1 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $2.62 | - | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $4.09 | - | 1 | Aug 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $6.73 | - | 1 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $2.13 | - | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $3.06 | - | 1 | Jul 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $18 | $2.39 | +653.14% | 1 | Jun 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $18.94 | - | 2 | Mar 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $80 → $90 | $313.08 | -71.25% | 2 | Feb 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $6.65 | - | 1 | Jan 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $216.45 | - | 1 | Nov 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $23 → $16 | $86.33 | -81.47% | 2 | Sep 28, 2017 |
Tempus AI
Dec 13, 2024
Initiates: Outperform
Price Target: $60
Current: $66.52
Upside: -9.80%
Hologic
Dec 13, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $65.01
Upside: -
Twist Bioscience
Dec 13, 2024
Initiates: Outperform
Price Target: $60
Current: $35.93
Upside: +66.99%
Stevanato Group
Dec 13, 2024
Initiates: Outperform
Price Target: $28
Current: $24.64
Upside: +13.64%
West Pharmaceutical Services
Dec 13, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $218.87
Upside: -
Repligen
Nov 14, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $123.56
Upside: -
Maravai LifeSciences Holdings
Nov 14, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $2.47
Upside: -
Danaher
Oct 31, 2024
Upgrades: Outperform
Price Target: $285
Current: $198.80
Upside: +43.36%
Bruker
Sep 30, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $41.80
Upside: -
Agilent Technologies
Jun 27, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $119.17
Upside: -
Jun 27, 2024
Upgrades: Outperform
Price Target: $52
Current: $47.77
Upside: +7.81%
Jun 27, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $11.73
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $94.79
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $53.65
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $408.28
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $5.27
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $97.82
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $1.29
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $13.53
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $50.86
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $167.96
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $352.41
Upside: -
Aug 17, 2021
Initiates: Outperform
Price Target: n/a
Current: $3.10
Upside: -
Aug 16, 2021
Initiates: Market Perform
Price Target: n/a
Current: $2.62
Upside: -
Aug 9, 2021
Initiates: Outperform
Price Target: n/a
Current: $4.09
Upside: -
Jan 12, 2021
Initiates: Outperform
Price Target: n/a
Current: $6.73
Upside: -
Dec 29, 2020
Initiates: Outperform
Price Target: n/a
Current: $2.13
Upside: -
Jul 7, 2020
Initiates: Outperform
Price Target: n/a
Current: $3.06
Upside: -
Jun 19, 2018
Initiates: Outperform
Price Target: $18
Current: $2.39
Upside: +653.14%
Mar 28, 2018
Upgrades: Outperform
Price Target: n/a
Current: $18.94
Upside: -
Feb 22, 2018
Maintains: Outperform
Price Target: $80 → $90
Current: $313.08
Upside: -71.25%
Jan 2, 2018
Initiates: Outperform
Price Target: n/a
Current: $6.65
Upside: -
Nov 1, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $216.45
Upside: -
Sep 28, 2017
Maintains: Outperform
Price Target: $23 → $16
Current: $86.33
Upside: -81.47%